Cargando…

Live birth after in vitro maturation versus standard in vitro fertilisation for women with polycystic ovary syndrome: protocol for a non-inferiority randomised clinical trial

INTRODUCTION: Polycystic ovary syndrome (PCOS) is the first common cause of anovulatory infertility. Currently, in vitro fertilisation (IVF) is recommended when conventional attempts have failed. In vitro maturation (IVM) of human oocytes is an emerging treatment option in infertile women with PCOS....

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Xiaoying, Guo, Wei, Zeng, Lin, Zheng, Danni, Yang, Shuo, Wang, Lina, Wang, Rui, Mol, Ben W, Li, Rong, Qiao, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Reproductive Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200037/ https://www.ncbi.nlm.nih.gov/pubmed/32295778 http://dx.doi.org/10.1136/bmjopen-2019-035334

Ejemplares similares

Effectiveness and safety of in vitro maturation of oocytes versus in vitro fertilisation in women with high antral follicle count: study protocol for a randomised controlled trial
por: Vuong, Lan N, et al.
Publicado: (2018)

Intracytoplasmic sperm injection (ICSI) versus conventional in vitro fertilisation (IVF) in couples with non-severe male infertility (NSMI-ICSI): protocol for a multicentre randomised controlled trial
por: Zheng, Danni, et al.
Publicado: (2019)

Outcomes of the Next In Vitro Fertilization Cycle in Women with Polycystic Ovary Syndrome after a Failed In Vitro Maturation Attempt
por: Guo, Wei, et al.
Publicado: (2023)

Effect of ethnicity on live birth rates after in vitro fertilisation or intracytoplasmic sperm injection treatment
por: Jayaprakasan, K, et al.
Publicado: (2014)

Observational retrospective study of US national utilisation patterns and live birth rates for various ovarian stimulation protocols for in vitro fertilisation
por: Kushnir, Vitaly A, et al.
Publicado: (2018)

Controlled ovarian hyperstimulation for poor ovarian responders undergoing in vitro fertilisation/intracytoplasmic sperm injection: a protocol for systematic review and Bayesian network meta-analysis
por: Yang, Huisheng, et al.
Publicado: (2021)

Association of urinary bisphenol A concentrations with in vitro fertilisation outcomes: a systematic review and meta-analysis protocol
por: Cao, Xian-Ling, et al.
Publicado: (2022)

Patient and professional perspectives about using in vitro fertilisation add-ons in the UK and Australia: a qualitative study
por: Armstrong, Sarah C, et al.
Publicado: (2023)

Comparison of in vitro maturation and in vitro fertilization for polycystic ovary syndrome patients—reply letter
por: Xu, Yalan, et al.
Publicado: (2022)

Vitamin D supplementation prior to in vitro fertilisation in women with polycystic ovary syndrome: a protocol of a multicentre randomised, double-blind, placebo-controlled clinical trial
por: Hu, Kai-Lun, et al.
Publicado: (2020)

Clinical Outcomes of In Vitro Maturation After Oocyte Retrieval With Gynecological Surgery for Refractory Polycystic Ovary Syndrome: A Retrospective Cohort Study
por: Zhang, Wen, et al.
Publicado: (2022)

OR35-03 Uncovering Causative Mutations in Polycystic Ovary Syndrome
por: Srivastava, Jaya, et al.
Publicado: (2023)

FRI409 Childbirth Experiences In Women With Polycystic Ovary Syndrome
por: Husby, Anne Engtrø, et al.
Publicado: (2023)

Live births after oocyte in vitro maturation with a prematuration step in women with polycystic ovary syndrome
por: Vuong, Lan N., et al.
Publicado: (2020)

Comparison of in vitro maturation and in vitro fertilization for polycystic ovary syndrome patients: a systematic review and meta-analysis
por: Xu, Yalan, et al.
Publicado: (2021)

MON-205 Is Muscle Mechanical Function Altered In Polycystic Ovary Syndrome?
por: Caliskan Guzelce, Ezgi, et al.
Publicado: (2019)

SAT-224 Polycystic Ovary Syndrome with Adrenal Hyperandrogenemia and Refractory Hirsutism
por: Parveen, Sanober, et al.
Publicado: (2019)

SUN-018 No Difference in Breastfeeding Rates in Women with Polycystic Ovary Syndrome
por: Bui, Leeann, et al.
Publicado: (2020)

FRI457 Protein-coding Genetic Variation In Polycystic Ovary Syndrome
por: Parker, Chloe, et al.
Publicado: (2023)

OR35-06 Polycystic Ovary Syndrome Is Associated With an Increased Mortality Risk
por: Ollila, Meri-Maija, et al.
Publicado: (2023)

Polycystic Ovary Syndrome as Metabolic Disease: New Insights on Insulin Resistance
por: Genazzani, Alessandro D, et al.
Publicado: (2023)

In vitro fertilisation (IVF) versus intracytoplasmic sperm injection (ICSI) in patients without severe male factor infertility: study protocol for the randomised, controlled, multicentre trial INVICSI
por: Berntsen, Sine, et al.
Publicado: (2021)

MON-215 Comparison of Ultrasonographic and Biochemical Markers of Polycystic Ovarian Morphology Across the Phenotypic Spectrum of Polycystic Ovary Syndrome
por: Jarrett, Brittany, et al.
Publicado: (2019)

Anaesthesia for In Vitro Fertilisation
por: Jain, Divya, et al.
Publicado: (2009)

Endometriosis and in vitro fertilisation
por: Vassilopoulou, Loukia, et al.
Publicado: (2018)

Live birth rate after human chorionic gonadotropin priming in vitro maturation in women with polycystic ovary syndrome
por: Ho, V. N. A., et al.
Publicado: (2018)

SAT-024 Investigating Racial and Ethnic Comorbidity Patterns of Polycystic Ovary Syndrome
por: Actkins, Ky’Era, et al.
Publicado: (2020)

Genetic Sex Effects of Polycystic Ovary Syndrome Reveal Distinct Metabolic Etiology
por: Actkins, Ky’Era, et al.
Publicado: (2021)

OR15-5 Cognitive Function in Reproductive Aged Individuals with Polycystic Ovary Syndrome
por: Cedars, Marcelle, et al.
Publicado: (2022)

SAT370 Economic Burden of Endometrial Cancer Associated with Polycystic Ovary Syndrome
por: Pace, Lauren Arielle, et al.
Publicado: (2023)

Effectiveness of a mobile preconception lifestyle programme in couples undergoing in vitro fertilisation (IVF): the protocol for the PreLiFe randomised controlled trial (PreLiFe-RCT)
por: Boedt, Tessy, et al.
Publicado: (2019)

Elevated ovarian pentraxin 3 in polycystic ovary syndrome
por: Pan, Jiexue, et al.
Publicado: (2021)

MON-223 Adipose Insulin Resistance in Normal-Weight Women with Polycystic Ovary Syndrome
por: Hoyos, Luis, et al.
Publicado: (2019)

MON-207 Identification of Monogenic Causes of Polycystic Ovary Syndrome by High Throughput Sequencing
por: Crespo, Raiane, et al.
Publicado: (2019)

SAT-017 Relationship Between Vitamin D Levels and Signs of Polycystic Ovary Syndrome
por: Smykalova, Anastasia, et al.
Publicado: (2020)

MON-037 Vitamin D Levels in Women with Polycystic Ovary Syndrome: Influence of Obesity
por: Maidana, Patricia Nieves Amelia, et al.
Publicado: (2020)

Overnight Melatonin Concentration and Sleep Quality Are Associated With Clinical Features of Polycystic Ovary Syndrome
por: Evans, Adam T, et al.
Publicado: (2021)

Lifestyle and Weight Change in Women With Polycystic Ovary Syndrome During COVID19 Pandemic
por: Eyupoglu, Nesrin Damla, et al.
Publicado: (2021)

SAT353 Relevance of Ovarian Morphology Among Adolescents With Polycystic Ovary Syndrome (PCOS)
por: Christ, Jacob P, et al.
Publicado: (2023)

SAT381 Effect of Obesity on Androgen-induced Splenic Dysregulation in Polycystic Ovary Syndrome
por: Rezq, Samar, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8jsmb2bnsero8gll4pr96vk5km